# Perioperative Systemic Lidocaine for Enhanced Bowel Recovery After Bariatric Surgery

> **NCT02607488** · PHASE1,PHASE2 · SUSPENDED · sponsor: **Mansoura University** · enrollment: 180 (estimated)

## Conditions studied

- Obesity
- Bariatric Surgery Candidate

## Interventions

- **DRUG:** Placebo
- **DRUG:** Lidocaine 1%
- **DRUG:** Lidocaine 1.5%
- **DRUG:** Lidocaine 2%

## Key facts

- **NCT ID:** NCT02607488
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2020-11
- **Primary completion:** 2022-12
- **Final completion:** 2023-02
- **Target enrollment:** 180 (ESTIMATED)
- **Why stopped:** No fund no enough recruiting centers
- **Last updated:** 2020-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02607488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02607488, "Perioperative Systemic Lidocaine for Enhanced Bowel Recovery After Bariatric Surgery". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02607488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*